Michela Chiappa
4PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jun 26, 2025
Onvansertib-Based Second-Line Therapies in Combination with Gemcitabine and Carboplatin in Patient-Derived Platinum-Resistant Ovarian Carcinomas.Federica Guffanti, Ilaria Mengoli, Francesca Ricci
|Jul 22, 2024
Onvansertib treatment overcomes olaparib resistance in high-grade ovarian carcinomas.Michela Chiappa, Alessandra Decio, Luca Guarrera
|Mar 13, 2024
Different Patterns of Platinum Resistance in Ovarian Cancer Cells with Homologous Recombination Proficient and Deficient Background.Michela Chiappa, Federica Guffanti, Chiara Grasselli
|Apr 12, 2022
Combinations of ATR, Chk1 and Wee1 Inhibitors with Olaparib Are Active in Olaparib Resistant Brca1 Proficient and Deficient Murine Ovarian Cells.Michela Chiappa, Federica Guffanti, Martina Anselmi
Pageof 1
Frequent Collaborators
4 joint publications
Federica Guffanti
4 joint publications
Giovanna Damia
2 joint publications
Simone Canesi
2 joint publications
Maya Ridinger
1 joint publications
Martina Anselmi
1 joint publications
Monica Lupi
1 joint publications
Lisa Wiesmüller
1 joint publications
Fabio Fiordaliso
1 joint publications
Luca Guarrera
1 joint publications
Maria C Barbera
